SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-013138
Filing Date
2018-05-16
Accepted
2018-05-16 21:17:43
Documents
2
Period of Report
2018-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1654
2 EX-24 DOCUMENT attachment1.htm EX-24 3724
  Complete submission text file 0000899243-18-013138.txt   6926
Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
BLUM LEONARD M (Reporting) CIK: 0001222247 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 18841570

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10